Smokoff Timothy sold $230K of VMD

Smokoff Timothy sold 20,000 shares of VIEMED HEALTHCARE, INC. (VMD) at an average of $11.50 ($11.41–$11.56, $0.23M total) across 5 trades on 2026-06-24.

Original reporting
SEC EDGAR · Smokoff Timothy
Published Jun 26, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VMD
Neutral
medium confidence
Mentioned
$VMD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VMDNeutralLow
01

Why it matters

A director’s open-market sale of 20,000 shares at roughly $11.50 each is disclosed, totaling about $229,967, with holdings after the sale of 75,518 shares.

02

Market read

Traders may monitor VMD for any clustering of insider selling or changes in trading behavior, but there is no fundamental catalyst in the text.

03

What to watch

The article does not provide context on total holdings, prior sale cadence, or whether other insiders sold around the same time, which limits inference from a single transaction.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-26, reporting sales executed 2026-06-24.

Background

The article is a SEC Form 4 insider transaction disclosure for VIEMED HEALTHCARE, Inc. (VMD).

Company-level read

Ticker impact

$VMDNeutralMedium confidence
Context

VIEMED HEALTHCARE director Smokoff Timothy sold about $229,967 of VMD shares in open-market transactions at $11.41 to $11.56.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-on selling or unusual volume around the sale window.

Evidence & confidence

This is a routine Form 4 insider transaction with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for diversification or liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • VIEMED HEALTHCARE, INC.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Smokoff Timothy

    Director who sold 20,000 shares across five trades on 2026-06-24.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VMDMedAI 8/10

Viemed Healthcare Q3 Earnings Call Highlights

VieMed Healthcare (VMD) reported Q3 operating cash flow of $11.5M and free cash flow of $4M. The company expects Q4 improvements in collections and active ventilator patients. Full-year revenue guidance was raised to $316M-$320M, while adjusted EBITDA was narrowed to $64M-$66M. VieMed had $9.7M in cash and $5.3M in borrowings at Q3's end, with a $1M share buyback and $2M term-loan repayment in October.

$VMDMed

Viemed Healthcare Inc (VMD) (Q3 2026) Earnings Call Highlights: Record Revenue

Viemed Healthcare reported Q3 2026 record revenue of $80M. CEO Casey Boyd discussed state rollout timelines, expecting gradual growth. CFO Trey Fitzgerald addressed sequential growth gaps, seasonal trends, and financial KPIs, targeting EBITDA above 20%. Accounts receivable delays impacted cash flow but are expected to resolve in Q4. Boyd also updated on sales force training, M&A pipeline, and patient education progress.

$VMDMed

VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

VIEMED HEALTHCARE, INC. (VMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (November 4, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, an

$VMDMedAI 8/10

Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands

Viemed Healthcare (NASDAQ: VMD) anticipates low-20% revenue growth in 2026, with projected revenue of $317M and EBITDA of $66M. The company's ventilator business averages $1,050 monthly per rental, with an average patient length of 17 months. Viemed has expanded into sleep therapy, maternal health, and other areas, completing three acquisitions in the past three years. The company has no net debt and has repurchased nearly 700,000 shares. Management sees organic growth and strategic acquisitions